PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY) Financial Reports 2018, News & Announcements 2018By Richard HopkinsMay 1, 2018180501_4C and Shareholders Update_March
PharmAust enters option to license agreement with Elanco for dog cancer treatment News & Announcements 2018By Richard HopkinsApril 18, 2018180418_Elanco PharmAust Agreement
Wayne Best appointed Epichem Chairman and Dr Keenan as CEO News & Announcements 2018By Richard HopkinsApril 10, 2018180410_Epichem New CEO_final
SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001 Financial Reports 2018, News & Announcements 2018By Richard HopkinsMarch 20, 2018180320_Cleansing Notice
Appendix 3B: New issue announcement, application for quotation of additional securities and agreement Financial Reports 2018, News & Announcements 2018By Richard HopkinsMarch 16, 2018180316_Appendix 3B and 3Y Notice
Appendix 3Y: Change of Director’s Interest Notice Financial Reports 2018, News & Announcements 2018By Richard HopkinsMarch 16, 2018180316_Change in Directors Interests
PharmAust new collaboration with leading cancer research institute on its MPL drug candidate News & Announcements 2018By Richard HopkinsMarch 14, 2018180312_PAA_ONJCRI collaboration_(clean)
Appendix 4D – Half Yearly Report for Dec, 2017 Financial Reports 2018, News & Announcements 2018By Richard HopkinsMarch 1, 2018R